Compare · CNMD vs PTHL
CNMD vs PTHL
Side-by-side comparison of CONMED Corporation (CNMD) and Pheton Holdings Ltd (PTHL): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CNMD and PTHL operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
- CNMD carries a market cap of $3.95B.
- Over the past year, CNMD is down 24.5% and PTHL is down 70.8% - CNMD leads by 46.3 points.
- CNMD has hit the wire 2 times in the past 4 weeks while PTHL has been quiet.
- CNMD has more recent analyst coverage (14 ratings vs 0 for PTHL).
- Company
- CONMED Corporation
- Pheton Holdings Ltd
- Price
- $38.41+2.52%
- $0.89+108.26%
- Market cap
- $3.95B
- -
- 1M return
- +3.74%
- +58.91%
- 1Y return
- -24.48%
- -70.82%
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Exchange
- NYSE
- NASDAQ
- IPO
- 1987
- 2024
- News (4w)
- 2
- 0
- Recent ratings
- 14
- 0
CONMED Corporation
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures worldwide. It offers orthopedic surgery products, including sports medicine products comprising powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, and metal and bioabsorbable implants, as well as related disposable products and fluid management systems; powered surgical instruments for use in bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries; sports biologics and tissue products; and surgical visualization products. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.
Latest CNMD
- SEC Form DEFA14A filed by CONMED Corporation
- SEC Form DEF 14A filed by CONMED Corporation
- SEC Form 4 filed by Beyer Pat
- CONMED Corporation to Announce First Quarter 2026 Financial Results on April 29, 2026
- Amendment: SEC Form SCHEDULE 13G/A filed by CONMED Corporation
- Amendment: SEC Form 4 filed by Lalomia Brent
- Amendment: SEC Form 4 filed by Schabacker Matthew
- Amendment: SEC Form 4 filed by Foust Hollie K
- Amendment: SEC Form 4 filed by Ferrell John D.
- Amendment: SEC Form 4 filed by Shagory Peter K
Latest PTHL
- SEC Form 6-K filed by Pheton Holdings Ltd
- Pheton Holdings Ltd Announces Corporate Name Change and Stock Ticker Symbol Change
- SEC Form 6-K filed by Pheton Holdings Ltd
- SEC Form 6-K filed by Pheton Holdings Ltd
- SEC Form 6-K filed by Pheton Holdings Ltd
- SEC Form 6-K filed by Pheton Holdings Ltd
- Pheton Holdings Ltd Announces Closing of Share Acquisition with iTonic Corporation
- SEC Form 6-K filed by Pheton Holdings Ltd
- SEC Form 6-K filed by Pheton Holdings Ltd
- SEC Form 6-K filed by Pheton Holdings Ltd